Date: March 27, 2013
PPE Gloves Reduce Exposure to Health Risks in the Delivery of Chemotherapy
As the area of new drug development for cancer evolves, so do the precautions and approaches to handling highly toxic chemotherapeutic drugs in a healthcare setting. In response to OSHA, CDC and NIOSH guidelines for preventing occupational hazards in the delivery of antineoplastic drugs (used to prevent the growth of cancer cells) RONCO today announced that it has a complete line of nitrile examination PPE gloves that have been tested for chemotherapy handling and administration. *
RONCO Blurite, RONCO Blurite Plus, RONCO NE5, RONCO NE4 and RONCO Touch gloves are latex-free, powder-free and have all been tested for breakdown and permeation in various chemo drug risk and exposure assessments. These RONCO premium quality nitrile gloves provide exceptional dexterity and tactile sensitivity and are manufactured with textured fingertips for easy grip. As an added safety feature, all RONCO nitrile gloves tear off in the presence of a puncture or pinhole.
RONCO President, Ron Pecchioli stated, “Sometimes the very drugs that heal us are hazardous in their own right, causing great physical risk to the people who handle and administer them. Worker safety becomes equally as important as patient protection in a healthcare setting.”
“RONCO is committed to excellence in serving our customers in this profession who have to follow local and national safety guidelines,” continued Mr. Pecchioli. “The R&D, testing and certification our products undergo is key to our obligations as safety specialists, not just glove manufacturers.”
Chemo testing of RONCO gloves ensures they are suitable for use by millions of healthcare workers across North America who may potentially be exposed to health hazards associated with the handling of cytotoxic solutions and powders used in chemotherapy. From pharmaceutical personnel, to oncologic nurses and physicians, emergency or longterm healthcare facility workers, laboratory researchers or veterinary care workers – right down to the people involved in the transport and receiving of these goods – RONCO nitrile gloves ensure proper protection against chemo drug handling risks.
RONCO Healthcare Specialist, Mario Lombardi, addressed the importance of personal protective equipment, particularly examination grade gloves, in the safe handling of cancer drugs, “The hazards of these chemo solutions and powders are well-documented as standards are being developed for the industry. Experts say there is no differentiation between high- and low-risk situations as there is always potential for contamination.”
“Testing these nitrile gloves to evaluate their performance in the safe handling of highly toxic cancer drugs was an important step we took in serving our healthcare community,” Mr. Lombardi continued. “A RONCO glove that has been tested for this type of impermeability should be an obvious choice for workers and reduce the practice of ‘double gloving’ in hospital, clinic or private practice settings.”
In addition to chemo tested gloves, RONCO has a complete range of products that offer maximum head, hand and body protection for operators, including coveralls and gowns, protective eyewear, shoe covers, respiratory protective equipment and head coverings. This PPE not only meets expectations for healthcare workers’ safety, it also prevents serious infection in high-risk patients.
*Note: For more specific information, please contact a RONCO product manager or healthcare specialist.
Established in 1996, RONCO is a world-class manufacturer of safety products. With a focus on consistent quality and outstanding customer service, RONCO has developed a strong presence across Canada for delivering safety solutions for Hand, Head and Body. RONCO is ISO 9001 and 13485 certified for the manufacture and distribution of non-sterile disposable medical examination gloves.
For more information, or to obtain samples of RONCO chemo tested nitrile gloves, please contact us at 905 660 6700 or firstname.lastname@example.org.
905 660 6700 ext. 275